S&P 500   5,046.47 (+0.48%)
DOW   38,008.03 (+0.67%)
QQQ   427.70 (+0.44%)
AAPL   168.13 (+0.08%)
MSFT   411.13 (-0.17%)
META   511.45 (+3.50%)
GOOGL   156.28 (+0.52%)
AMZN   182.24 (+0.53%)
TSLA   151.42 (-2.59%)
NVDA   855.56 (+1.81%)
AMD   155.91 (+1.23%)
NIO   4.05 (+3.58%)
BABA   69.42 (+0.87%)
T   16.17 (+0.31%)
F   12.13 (+0.75%)
MU   115.18 (-0.99%)
GE   156.71 (+0.67%)
CGC   7.83 (+20.65%)
DIS   114.03 (+0.97%)
AMC   2.92 (-2.01%)
PFE   25.38 (-0.16%)
PYPL   62.83 (-0.68%)
XOM   118.90 (+0.23%)
S&P 500   5,046.47 (+0.48%)
DOW   38,008.03 (+0.67%)
QQQ   427.70 (+0.44%)
AAPL   168.13 (+0.08%)
MSFT   411.13 (-0.17%)
META   511.45 (+3.50%)
GOOGL   156.28 (+0.52%)
AMZN   182.24 (+0.53%)
TSLA   151.42 (-2.59%)
NVDA   855.56 (+1.81%)
AMD   155.91 (+1.23%)
NIO   4.05 (+3.58%)
BABA   69.42 (+0.87%)
T   16.17 (+0.31%)
F   12.13 (+0.75%)
MU   115.18 (-0.99%)
GE   156.71 (+0.67%)
CGC   7.83 (+20.65%)
DIS   114.03 (+0.97%)
AMC   2.92 (-2.01%)
PFE   25.38 (-0.16%)
PYPL   62.83 (-0.68%)
XOM   118.90 (+0.23%)
S&P 500   5,046.47 (+0.48%)
DOW   38,008.03 (+0.67%)
QQQ   427.70 (+0.44%)
AAPL   168.13 (+0.08%)
MSFT   411.13 (-0.17%)
META   511.45 (+3.50%)
GOOGL   156.28 (+0.52%)
AMZN   182.24 (+0.53%)
TSLA   151.42 (-2.59%)
NVDA   855.56 (+1.81%)
AMD   155.91 (+1.23%)
NIO   4.05 (+3.58%)
BABA   69.42 (+0.87%)
T   16.17 (+0.31%)
F   12.13 (+0.75%)
MU   115.18 (-0.99%)
GE   156.71 (+0.67%)
CGC   7.83 (+20.65%)
DIS   114.03 (+0.97%)
AMC   2.92 (-2.01%)
PFE   25.38 (-0.16%)
PYPL   62.83 (-0.68%)
XOM   118.90 (+0.23%)
S&P 500   5,046.47 (+0.48%)
DOW   38,008.03 (+0.67%)
QQQ   427.70 (+0.44%)
AAPL   168.13 (+0.08%)
MSFT   411.13 (-0.17%)
META   511.45 (+3.50%)
GOOGL   156.28 (+0.52%)
AMZN   182.24 (+0.53%)
TSLA   151.42 (-2.59%)
NVDA   855.56 (+1.81%)
AMD   155.91 (+1.23%)
NIO   4.05 (+3.58%)
BABA   69.42 (+0.87%)
T   16.17 (+0.31%)
F   12.13 (+0.75%)
MU   115.18 (-0.99%)
GE   156.71 (+0.67%)
CGC   7.83 (+20.65%)
DIS   114.03 (+0.97%)
AMC   2.92 (-2.01%)
PFE   25.38 (-0.16%)
PYPL   62.83 (-0.68%)
XOM   118.90 (+0.23%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$134.16
-0.3%
$141.22
$96.80
$151.58
$39.32B1.111.57 million shs804,846 shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$281.26
-3.3%
$331.66
$261.59
$489.36
$8.02B0.87198,761 shs161,213 shs
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$1,206.12
+0.7%
$1,269.99
$928.49
$1,601.66
$25.80B1.15140,428 shs62,085 shs
Revvity, Inc. stock logo
PKI
Revvity
$127.73
$113.46
$170.00
$14.57B1.1851,117 shs1.63 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-1.58%-6.67%-7.90%+3.14%-3.20%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-0.71%-12.17%-12.79%-4.38%-39.31%
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
-2.43%-8.33%-8.28%+1.10%-24.62%
Revvity, Inc. stock logo
PKI
Revvity
0.00%0.00%0.00%0.00%-14.08%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
4.0551 of 5 stars
2.33.01.73.72.20.82.5
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6507 of 5 stars
3.44.00.04.21.83.31.9
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
3.6691 of 5 stars
1.15.00.03.32.32.52.5
Revvity, Inc. stock logo
PKI
Revvity
4.1175 of 5 stars
3.50.01.73.50.01.74.4

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.59
Moderate Buy$141.295.32% Upside
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0066.39% Upside
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
2.17
Hold$1,233.252.25% Upside
Revvity, Inc. stock logo
PKI
Revvity
3.00
Buy$115.50∞ Upside

Current Analyst Ratings

Latest A, MTD, BIO, and PKI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$125.00 ➝ $135.00
4/5/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$145.00 ➝ $163.00
4/4/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$132.00 ➝ $145.00
4/4/2024
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$1,200.00 ➝ $1,300.00
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
3/26/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$67.00 ➝ $90.00
2/28/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$130.00 ➝ $155.00
2/28/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$130.00 ➝ $145.00
2/28/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$135.00 ➝ $132.00
2/28/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$120.00 ➝ $125.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$395.00 ➝ $420.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.83B5.75$6.30 per share21.29$19.98 per share6.71
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B3.00$11.63 per share24.18$306.51 per share0.92
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$3.79B6.81$43.73 per share27.58($6.98) per share-172.80
Revvity, Inc. stock logo
PKI
Revvity
$3.31B0.00N/A9.88$58.49 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.24B$4.2031.9422.104.1418.35%27.09%14.66%5/28/2024 (Estimated)
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A24.54N/A-23.86%3.90%2.77%5/2/2024 (Estimated)
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$788.78M$35.8933.6127.063.3520.82%-904.59%24.93%5/9/2024 (Confirmed)
Revvity, Inc. stock logo
PKI
Revvity
$569.18M$7.6815.010.000.5028.94%11.17%5.83%N/A

Latest A, MTD, BIO, and PKI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$7.63N/A-$7.63N/AN/AN/A  
2/27/2024Q1 24
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.22$1.29+$0.07$1.40$1.59 billion$1.66 billion    
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      
2/9/2024Q4 2023
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$10.32$9.40-$0.92$10.28$959.45 million$934.90 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$0.940.70%+19.04%22.38%1 Years
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
N/AN/AN/AN/AN/A
Revvity, Inc. stock logo
PKI
Revvity
$0.28N/AN/A3.65%N/A

Latest A, MTD, BIO, and PKI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Quarterly$0.23600.72%4/1/20244/2/20244/24/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.41
2.68
2.04
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
N/A
1.04
0.71
Revvity, Inc. stock logo
PKI
Revvity
0.48
2.43
2.15

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
95.07%
Revvity, Inc. stock logo
PKI
Revvity
85.22%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.06%
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
1.94%
Revvity, Inc. stock logo
PKI
Revvity
0.52%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100293.05 millionN/AOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.65 millionOptionable
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
17,30021.39 million20.97 millionOptionable
Revvity, Inc. stock logo
PKI
Revvity
16,700126.41 million125.76 millionOptionable

A, MTD, BIO, and PKI Headlines

SourceHeadline
Revvity Inc PKIRevvity Inc PKI
morningstar.com - February 13 at 11:31 PM
Revvity revenue drops 17% in first year after PerkinElmer spinout, thanks to COVID testing declinesRevvity revenue drops 17% in first year after PerkinElmer spinout, thanks to COVID testing declines
fiercebiotech.com - February 1 at 1:35 PM
PerkinElmer buys Covaris to boost next-gen life sciences offeringsPerkinElmer buys Covaris to boost next-gen life sciences offerings
mmm-online.com - December 4 at 6:14 PM
PerkinElmer picks up Covaris’ sample prep portfolio in New Mountain-led dealPerkinElmer picks up Covaris’ sample prep portfolio in New Mountain-led deal
fiercebiotech.com - December 4 at 1:13 PM
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCIDRevvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
businesswire.com - December 1 at 12:46 PM
Revvity and Sciex Collaborate To Provide Innovative Neonatal Mass Spectrometry SolutionRevvity and Sciex Collaborate To Provide Innovative Neonatal Mass Spectrometry Solution
technologynetworks.com - November 1 at 1:55 AM
Revvity Stock (NYSE:RVTY), Analyst Ratings, Price Targets, PredictionsRevvity Stock (NYSE:RVTY), Analyst Ratings, Price Targets, Predictions
benzinga.com - November 1 at 1:55 AM
Revvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis SolutionsRevvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis Solutions
finance.yahoo.com - October 29 at 11:18 AM
Revvity, IncRevvity, Inc
moneycontrol.com - August 3 at 2:11 AM
Revvity (RVTY) Beats on Q2 Earnings, Lowers 23 EPS ViewRevvity (RVTY) Beats on Q2 Earnings, Lowers '23 EPS View
finance.yahoo.com - August 2 at 11:03 AM
Revvity (NYSE: PKI)Revvity (NYSE: PKI)
fool.com - August 1 at 8:00 PM
Revvity (RVTY) to Report Q2 Earnings: Whats in the Cards?Revvity (RVTY) to Report Q2 Earnings: What's in the Cards?
finance.yahoo.com - July 31 at 10:32 AM
PerkinElmer Completes Transformation to Become RevvityPerkinElmer Completes Transformation to Become Revvity
finance.yahoo.com - May 19 at 2:37 PM
Revvity Announces New License Agreement for Next-Generation Base Editing TechnologyRevvity Announces New License Agreement for Next-Generation Base Editing Technology
finance.yahoo.com - May 18 at 10:18 AM
J.P. Morgan Keeps Their Hold Rating on PerkinElmer (PKI)J.P. Morgan Keeps Their Hold Rating on PerkinElmer (PKI)
markets.businessinsider.com - May 16 at 12:37 PM
Citigroup Maintains Revvity (PKI) Buy RecommendationCitigroup Maintains Revvity (PKI) Buy Recommendation
msn.com - May 15 at 9:36 PM
Analyst Ratings for RevvityAnalyst Ratings for Revvity
markets.businessinsider.com - May 15 at 4:36 PM
PerkinElmer (PKI) Receives a Buy from CitigroupPerkinElmer (PKI) Receives a Buy from Citigroup
markets.businessinsider.com - May 15 at 9:40 AM
Barclays Maintains Perkinelmer (PKI) Equal-Weight RecommendationBarclays Maintains Perkinelmer (PKI) Equal-Weight Recommendation
msn.com - May 13 at 8:08 AM
PerkinElmer: Q1 Earnings Snapshot - Seattle PIPerkinElmer: Q1 Earnings Snapshot - Seattle PI
news.google.com - May 12 at 9:15 PM
PerkinElmer Q1 23 Earnings Conference Call At 8:00 AM ET - NasdaqPerkinElmer Q1 23 Earnings Conference Call At 8:00 AM ET - Nasdaq
news.google.com - May 12 at 9:15 PM
Skandinaviska Enskilda Banken AB publ Has $2.92 Million Position ... - MarketBeatSkandinaviska Enskilda Banken AB publ Has $2.92 Million Position ... - MarketBeat
news.google.com - May 12 at 9:15 PM
PerkinElmer Non-GAAP EPS of $1.01 misses by $0.01, revenue of ... - Seeking AlphaPerkinElmer Non-GAAP EPS of $1.01 misses by $0.01, revenue of ... - Seeking Alpha
news.google.com - May 12 at 9:15 PM
PerkinElmer Enters Oversold Territory (PKI) - NasdaqPerkinElmer Enters Oversold Territory (PKI) - Nasdaq
news.google.com - May 12 at 9:15 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Agilent Technologies logo

Agilent Technologies

NYSE:A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Mettler-Toledo International logo

Mettler-Toledo International

NYSE:MTD
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.
Revvity logo

Revvity

NYSE:PKI
Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.